What will become of biotech in 2019?
What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT's Ike Swetlitz joins us to discuss the IBM's latest travails with Watson Health, the purportedly revolutionary technology that has quickly become a cautionary tale. Then, we look forward to 2019 and the major biotech stories we'll be keeping an eye on throughout the year. Finally, Ed Kaye, CEO of Stoke Therapeutics, joins us to talk about his new company, relive his days at Sarepta, and, bravely, answer rapid-fire questions in a lightning round.
You can listen to the episode here. To listen to future episodes, be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.